1-3 of 3
Bozena Jazwiec, MSC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD PhD, Bozena Jazwiec, MSC, Tomasz Wrobel, MDPhD, Kazimierz Kuliczkowski, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 3152.
https://doi.org/10.1182/blood.V124.21.3152.3152
Published: 2014
Journal Articles

CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD, PhD, Prof., Bozena Jazwiec, MSC, Joanna Urbaniak, PhD, Mieczyslaw Wozniak, PhD Prof., Kazimierz Kuliczkowski, Professor
Journal: Blood
Blood (2013) 122 (21): 3990.
https://doi.org/10.1182/blood.V122.21.3990.3990
Published: 2013
Journal Articles

Expression of PIM-2 and NF-κB Is Increased in Patients with Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) and Correlates with Complete Remission Rate

Katarzyna Kapelko-Slowik, MD, PhD, Donata Urbaniak-Kujda, MD, PhD, Dariusz Wolowiec, Jaroslaw Dybko, Bozena Jazwiec, MSC, Miroslaw Slowik, MD, PhD, Jacek Jakubaszko, MD, Tomasz Owczarek, MSC, Krzysztof Grzymajlo, MSC, Kazimierz Kuliczkowski
Journal: Blood
Blood (2011) 118 (21): 4648.
https://doi.org/10.1182/blood.V118.21.4648.4648
Published: 2011